BlackRock’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Sell |
2,882,109
-3,472,424
| -55% | -$2.55M | ﹤0.01% | 3974 |
|
|
2025
Q1 | $6.35M | Sell |
6,354,533
-752,463
| -11% | -$752K | ﹤0.01% | 3498 |
|
|
2024
Q4 | $75.3M | Buy |
7,106,996
+920,102
| +15% | +$9.75M | ﹤0.01% | 2204 |
|
|
2024
Q3 | $81.7M | Buy |
6,186,894
+1,583,500
| +34% | +$20.9M | ﹤0.01% | 2173 |
|
|
2024
Q2 | $45.3M | Buy |
4,603,394
+3,617,823
| +367% | +$35.6M | ﹤0.01% | 2435 |
|
|
2024
Q1 | $13.6M | Sell |
985,571
-58,433
| -6% | -$803K | ﹤0.01% | 3135 |
|
|
2023
Q4 | $17.8M | Buy |
1,044,004
+1,019,004
| +4,076% | +$17.4M | ﹤0.01% | 3019 |
|
|
2023
Q3 | $353K | Buy |
+25,000
| New | +$353K | ﹤0.01% | 4453 |
|